© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ONC LNG PLSM ALYS 388 PRTN | Medium Descr | ONC LNG PLSM ALYS 388 PRTN APTMR BSD PRTOMC TECH | Long Descr | Oncology (lung), plasma analysis of 388 proteins, using aptamer-based proteomics technology, predictive algorithm reported as clinical benefit from immune checkpoint inhibitor therapy | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Added | First appearance of addition in codebook. |
| 2024-01-01 | Added | Code Added. |
Get instant expert-level medical coding assistance.